Development of Standardized Milk Thistle Product

Information

  • Research Project
  • 6399638
  • ApplicationId
    6399638
  • Core Project Number
    R42AT000766
  • Full Project Number
    1R42AT000766-01
  • Serial Number
    766
  • FOA Number
    RFA-AT-00-03
  • Sub Project Id
  • Project Start Date
    9/20/2001 - 23 years ago
  • Project End Date
    7/14/2002 - 22 years ago
  • Program Officer Name
    KLEIN, MARGUERITE A
  • Budget Start Date
    9/20/2001 - 23 years ago
  • Budget End Date
    7/14/2002 - 22 years ago
  • Fiscal Year
    2001
  • Support Year
    1
  • Suffix
  • Award Notice Date
    9/15/2001 - 23 years ago

Development of Standardized Milk Thistle Product

DESCRIPTION (Provided by applicant): The objective of this Phase I and II fast track application is to develop a standardized milk thistle product and to assure a quality controlled and reliable source for future basic and clinical studies. Natural Pharmacia International, Inc, an established natural products laboratory, has established an excellent consortial team to establish a standardized milk thistle product following FDA guidelines. The key to the success of this program as it has been conceived, is the cooperative efforts of experts in botanical identification, cultivation, natural products chemistry, chemical synthesis and analysis, quality assurance and control, toxicity evaluation, bioavailability and pharmacokinetics analysis, in vitro and in vivo liver disease models, formulation and regulatory issues including DMS (drug master file) and IND (investigational new drug) filing. In addition, NPI proposed an outstanding business plan, which includes the source of the milk thistle seed extract, GMP manufacturing and packaging, storage, inventory, and distribution of the standardized product and placebo in Phase III. PROPOSED COMMERCIAL APPLICATION: This research may lead to the development of a standardized milk thistle product for treatment of liver diseases.

IC Name
NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE
  • Activity
    R42
  • Administering IC
    AT
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    221244
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    213
  • Ed Inst. Type
  • Funding ICs
    NCCAM:221244\
  • Funding Mechanism
  • Study Section
    ZAT1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    NATURAL PHARMACIA INTERNATIONAL, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    Burlington
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    01803
  • Organization District
    UNITED STATES